Literature DB >> 24559002

Restriction of dairy products; a reality in inflammatory bowel disease patients.

Mirella Brasil Lopes1, Raquel Rocha1, André Castro Lyra2, Vanessa Rosa Oliveira3, Fernanda Gomes Coqueiro3, Naiade Silveira Almeida3, Sandra Santos Valois3, Genoile Oliveira Santana2.   

Abstract

INTRODUCTION: Calcium deficiency is considered a risk factor for the development of osteoporosis in inflammatory bowel disease (IBD) patients. Various dietary restrictions, including milk products are reported by these patients.
OBJECTIVE: To evaluate dairy product and dietary calcium intake by IBD patients.
METHODS: This cross-sectional study enrolled 65 outpatients with IBD recruited from one reference center for IBD. A semi-structured questionnaire (to collect demographic, socioeconomic and clinical data) and a quantitative food frequency questionnaire were administered. With regard to clinical data, we evaluated the anthropometric nutritional status, the disease classification, the disease activity index and the presence of gastrointestinal symptoms. Self-reported modifications in the use of dairy products were evaluated.
RESULTS: The IBD patients' ages ranged from 20-75 years and 67.0% were diagnosed with ulcerative colitis. The majority (64.7%) reported restricting dairy products. The frequency of gastrointestinal symptoms was higher among the Crohn's disease patients who restricted dairy products than among those with no restrictions (100% vs 42.9%; p = 0.013); this result was not observed among the UC (ulcerative colitis) patients. Disease activity was also more frequent in the IBD patients who restricted dairy products than in those with no restrictions (23.8% vs 4.5%; p = 0.031), and among the UC patients, extensive disease was more common in the patients who restricted dairy products than in those with no restrictions (42.9% vs 20.0%; p = 0.03).
CONCLUSION: Restricting dairy products is common among IBD patients, possibly due to disease activity, the presence of gastrointestinal symptoms and the extension of the disease. Copyright AULA MEDICA EDICIONES 2014. Published by AULA MEDICA. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24559002     DOI: 10.3305/nh.2014.29.3.7124

Source DB:  PubMed          Journal:  Nutr Hosp        ISSN: 0212-1611            Impact factor:   1.057


  15 in total

1.  Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.

Authors:  May-Bente Bengtson; Christopher F Martin; Geir Aamodt; Morten H Vatn; Uma Mahadevan
Journal:  Dig Dis Sci       Date:  2017-03-22       Impact factor: 3.199

2.  Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Thea Myklebust-Hansen; Geir Aamodt; Margaretha Haugen; Anne Lise Brantsæter; Morten H Vatn; May-Bente Bengtson
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

3.  Influence of Diet on the Course of Inflammatory Bowel Disease.

Authors:  Laura Tasson; Cristina Canova; Maria Grazia Vettorato; Edoardo Savarino; Renzo Zanotti
Journal:  Dig Dis Sci       Date:  2017-05-26       Impact factor: 3.199

Review 4.  Diets for inflammatory bowel disease: What do we know so far?

Authors:  Clara Serrano-Moreno; Noemi Brox-Torrecilla; Loredana Arhip; Inmaculada Romero; Ángela Morales; M Luisa Carrascal; Cristina Cuerda; Marta Motilla; Miguel Camblor; Cristina Velasco; Irene Bretón
Journal:  Eur J Clin Nutr       Date:  2022-01-22       Impact factor: 4.884

Review 5.  The role of enteral nutrition in patients with inflammatory bowel disease: current aspects.

Authors:  John K Triantafillidis; Costas Vagianos; Apostolos E Papalois
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

Review 6.  The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials.

Authors:  Maria Jose Saez-Lara; Carolina Gomez-Llorente; Julio Plaza-Diaz; Angel Gil
Journal:  Biomed Res Int       Date:  2015-02-22       Impact factor: 3.411

Review 7.  Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseases.

Authors:  Andrew Szilagyi; Polymnia Galiatsatos; Xiaoqing Xue
Journal:  Nutr J       Date:  2016-07-13       Impact factor: 3.271

Review 8.  Dietary Management in Pediatric Patients with Crohn's Disease.

Authors:  Luca Scarallo; Paolo Lionetti
Journal:  Nutrients       Date:  2021-05-11       Impact factor: 5.717

9.  A cross-sectional study on nutrient intake and -status in inflammatory bowel disease patients.

Authors:  Jona B Vidarsdottir; Sigridur E Johannsdottir; Inga Thorsdottir; Einar Bjornsson; Alfons Ramel
Journal:  Nutr J       Date:  2016-06-08       Impact factor: 3.271

10.  Association Between Change in Inflammatory Aspects of Diet and Change in IBD-related Inflammation and Symptoms Over 1 Year: The Manitoba Living With IBD Study.

Authors:  Kathy Vagianos; Leigh Anne Shafer; Kelcie Witges; Laura E Targownik; Clove Haviva; Lesley A Graff; Kathryn A Sexton; Lisa M Lix; Michael Sargent; Charles N Bernstein
Journal:  Inflamm Bowel Dis       Date:  2021-01-19       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.